Advanced cellular and high-content screening platforms to investigate TDP-43 pathology and splicing dysfunction in ALS/FTD, enabling discovery and validation of novel therapeutic targets and modulators for neurodegenerative disorders.
Alessandro Cinti, Scientific Research Expert, Axxam
